Logo image
Disproportionate contribution of right middle lobe to emphysema and gas trapping on computed tomography
Journal article   Open access   Peer reviewed

Disproportionate contribution of right middle lobe to emphysema and gas trapping on computed tomography

Surya P Bhatt, Jessica C Sieren, John D Newell Jr, Alejandro P Comellas and Eric A Hoffman
PloS one, Vol.9(7), pp.e102807-e102807
2014
DOI: 10.1371/journal.pone.0102807
PMCID: PMC4108372
PMID: 25054539
url
https://doi.org/10.1371/journal.pone.0102807View
Published (Version of record) Open Access

Abstract

Given that the diagnosis of chronic obstructive pulmonary disease (COPD) relies on demonstrating airflow limitation by spirometry, which is known to be poorly sensitive to early disease, and to regional differences in emphysema, we sought to evaluate individual lobar contributions to global spirometric measures. Subjects with COPD were compared with smokers without airflow obstruction, and non-smokers. Emphysema (% low attenuation area, LAAinsp<-950 HU, at end-inspiration) and gas trapping (%LAAexp<-856 HU at end-expiration) on CT were quantified using density mask analyses for the whole lung and for individual lobes, and distribution across lobes and strength of correlation with spirometry were compared. The right middle lobe had the highest %LAAinsp<-950 HU in smokers and controls, and the highest %LAAexp<-856 HU in all three groups. While RML contributed to emphysema and gas trapping disproportionately to its relatively small size, it also showed the least correlation with spirometry. There was no change in correlation of whole lung CT metrics with spirometry when the middle lobe was excluded from analyses. Similarly, RML had the highest %LAAexp<-856 HU while having the least correlation with spirometry. Because of the right middle lobe's disproportionate contribution to CT-based emphysema measurements, and low contribution to spirometry, longitudinal studies of emphysema progression may benefit from independent analysis of the middle lobe in whole lung quantitative CT assessments. Our findings may also have implications for heterogeneity assessments and target lobe selection for lung volume reduction. ClinicalTrials.gov NCT00608764.
Lung - pathology Pulmonary Emphysema - physiopathology Cross-Sectional Studies Humans Middle Aged Tomography, X-Ray Computed - methods Male Lung - diagnostic imaging Lung - physiopathology Pulmonary Disease, Chronic Obstructive - physiopathology Pulmonary Emphysema - diagnostic imaging Forced Expiratory Volume Young Adult Analysis of Variance Spirometry - methods Smoking - physiopathology Aged, 80 and over Adult Female Aged

Details

Metrics

Logo image